济南痛风特征性表现山东中医治疗痛风的好方法,济南急性痛风性关节炎怎么治,山东什么原因能引起尿酸高,山东痛风中治疗方案,济南痛风怎样控制饮食,济南痛风石怎么溶解排出,山东痛风病人能吃橄榄菜吗

BEIJING, Jan. 5 (Xinhua) -- The U.S. Secretary of Treasury Timothy Geithner will visit China from Jan. 10 to 11 as a special representative of the U.S. President Barack Obama, Chinese Foreign Ministry spokesman Hong Lei announced on Thursday.Timothy Geithner's visit is at the invitation of Chinese Vice Premier Wang Qishan, said Hong.Chinese top leaders will meet with Timothy Geithner and exchange views with him on issues concerning Sino-US economical relations and the world's economic and financial situations, Hong said.

BEIJING, Oct. 11 (Xinhuanet) -- Debates in the medical field developed on Monday as a U.S. government panel recommended that men of all ages should stop getting prostate cancer blood screenings.The United States Preventive Services examined all the evidence and found little if any reduction in deaths from routine P.S.A. screening and suggested that the test does more harm than good to healthy men.The P.S.A. test for prostate cancer, a blood test to screen for a protein that may indicate cancer, has become widely used because it can help detect tiny tumors at a very early sta ge, when they are theoretically most treatable.Unfortunately, according to the task force, the vast majority of the results are false-positives: the men don’t actually have cancer. And most of those found to have cancerous cells would not suffer ill effects because their cancer is so slow-growing that it would not cut short their lives. Those with faster-growing cancers may also not be helped if the cancer is extremely aggressive.After the recommendation came out last week, many prostate cancer specialists have been pushing back.Urologist Dr. Mark DeGuenther said this recommendation is more about saving money than saving lives. He said death rates from prostate cancer have dropped 40 percent since men began getting screened at age 40 and he says it will save taxpayers and patients more money in the long run to diagnose and treat cancers earlier rather than wait and have to provide expensive care for advanced stage cancers."We all agree that we've got to do a better job of figuring out who would benefit from P.S.A. screening," said Dr. Scott Eggener, a prostate cancer specialist at the University of Chicago. "But a blanket statement of just doing away with it altogether ... seems over-aggressive and irresponsible."Dr. Deepak Kapoor, chairman and chief executive of Integrated Medical Professionals, which includes the nation's largest urology practice, said "We will not allow patients to die, which is what will happen if this recommendation is accepted."That task force's recommendation isn't final - it's a draft open for public debate. And obviously the debate is already under way.

WASHINGTON, Nov. 24 (Xinhua) -- An inexpensive drug that treats Type 2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher. The research, led by pediatrics professor James Trosko and colleagues from South Korea's Seoul National University, provides biological evidence for previously reported epidemiological surveys that long-term use of the drug metformin for Type 2 diabetes reduces the risk of diabetes-associated cancers, such as breast cancers.The research appeared online this week in PLoS One.For the study, Trosko and colleagues focused on the concept that cancers originate from adult human stem cells and that there are many natural and man-made chemicals that enhance the growth of breast cancer cells. Using culture dishes, they grew miniature human breast tumors, or mammospheres, that activated a certain stem cell gene. Then the mammospheres were exposed to natural estrogen -- a known growth factor and potential breast tumor promoter -- and man-made chemicals that are known to promote tumors or disrupt the endocrine system.The team found that estrogen and the chemicals caused the mammospheres to increase in numbers and size. However, with metformin added, the numbers and size of the mammospheres were dramatically reduced. While each of the chemicals enhanced growth by different means, metformin seemed to be able to inhibit their stimulated growth in all cases."While future studies are needed to understand the exact mechanism by which metformin works to reduce the growth of breast cancers, this study reveals the need to determine if the drug might be used as a preventive drug and for individuals who have no indication of any existing cancers," Trosko said.

YANGON, Nov. 10 (Xinhua) -- Myanmar surgeons have successfully separated the fifth conjoined twin baby girls, official media reported Thursday.The surgical operation by Dr. Htoo Han and his assistants was performed on the two-year-and-one-month-old conjoined twins named Ma Ingyin Khaing and Ma Ingyin Hlaing in the Children's Hospital in Yangon Wednesday, according to the New Light of Myanmar daily.The separated twins, who are under extensive care in the hospital, are from Kawtin village in Laungton township in southern Tanintharyi region.Myanmar surgeons had carried out four successful similar surgical operations on twins in the past over two decades.The fourth twins, who are also baby girls named So Pyay Lin and So Pyay Win with their chests joined together, were successfully separated in October 2009.

BEIJING, Nov. 13 (Xinhua) -- China has established an operation committee for management of the country's first space lab module, Tiangong-1, during its two-year orbit of earth.The committee will deal with operations planning, technical appraisal and flight control of the target orbiter after the unmanned Shenzhou-8 spacecraft returns to earth after its mission, the official website of China's manned space program said.The Tiangong-1 space lab module was launched on Sept. 29 and docked with Shenzhou-8 precisely on Nov. 3, China's first ever space docking attempt. The second docking between Tiangong-1 and Shenzhou-8 is scheduled for Nov. 14.The manned space program said earlier that the same target orbiter Tiangong-1 will accommodate another two docking missions performed by two other Shenzhou spaceships, at least one of which will be manned.The 8.5-tonne Tiangong-1 is the first space lab module that China has built, and the committee will also be the first in taking care of a long-running space asset.The operation committee for Tiangong-1 heralds China's manned space program entering a new phase for lengthy flight missions, Niu Hongguang, director of the operation committee, said on the website www.cmse.gov.cn.The orbiting module management will include taking care of the space lab, making preparations for any further docking tests and gathering experience for building a future space station, Niu said.